Back to results
US 6,060,598 AGranted
Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding
AssigneeHyperion, Inc.
InventorsRobert Francis Devlin, Walter Beach Dandliker, Peter Olaf Gustaf Arrhenius
Life of this patent
Estimating the term…
Abstract
Fluorescence immunoassays methods are provided which use fluorescent dyes which are free of aggregation and serum binding. Such immunoassay methods are thus, particularly useful for the assay of biological fluids, such as serum, plasma, whole blood and urine.
Claims19
A fluorescent probe comprising a marker component linked to a target analyte or a analog thereof, wherein:
- (a) said marker component comprises a fluorophore moiety comprising a luminescent substantially planar molecular structure coupled to two polyoxyhydrocarbyl moieties, one located on either side of the planar molecular structure;
- (i) wherein said luminescent substantially planar molecular structure comprises a substantially planar macrocylic multidentate ligand which coordinates to a central atom,
- (ii) wherein said central atom coordinates to said polyoxyhydrocarbyl moieties,
- (iii) wherein said multidentate ligand comprises an optionally substituted nitrogen containing macrocycle selected from the group consisting of a porphyrin and an azaporphyrin derivative and
- (b) said planar molecular structure is linked at adjacent sites of the periphery of said structure to a carboxyl group and said target analyte or said analog thereof, wherein said target analyte is selected from the group consisting of an antigen, a hapten, an antibody, a drug selected from the group consisting of a steroid, a hormone, an antiasthmatic, an antineoplastic, an antiarrhythmic, an anticonvulsant, an antiarthritic, an antidepressant, and a cardiac glycoside, a metabolite of the drug, and a peptide and wherein said target analyte comprises a free primary or secondary amino group or a free carboxyl group.
2 more elements
Dependencies are inferred from the claim text.